# Terlipressin

## Glypressin inj 1mg

| TAH Drug Code      | [IGLYP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IGLYP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of bleeding esophageal varices, and type 1 hepatorenal syndrome, characterised by spontaneous acute renal insufficiency, in patients suffering from severe cirrhosis with ascites.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Bleeding oesophageal varices: Adults: Initially an IV injection of 2 ampoules of GLYPRESSINR solution for injection (2 mg terlipressin acetate, equivalent to 1.7 mg terlipressin) is given every 4 hours. The treatment should be maintained until bleeding has been controlled but up to a maximum of 48 hours. The dose can be adjusted to 1 ampoule of GLYPRESSINR solution for injection (1 mg terlipressin acetate, equivalent to 0.85 mg terlipressin) IV every 4 hours in patients with body weight < 50 kg. For maintenance dosage (if necessary), bolus injection of 1 ampoule of GLYPRESSINR solution for injection every 4 hours for a maximum of 3 days. Duration of treatment must not exceed 5 days. In type 1 hepatorenal syndrome: 3 to 4 ampoules of GLYPRESSINR solution for injection (3 to 4 mg terlipressin acetate, equivalent to 2.55 to 3.4 mg terlipressin) every 24 hours as 3 or 4 administrations. In the absence of any reduction of the serum creatinine after 3 days of treatment, cessation of GLYPRESSINR treatment is advised. In the other cases, GLYPRESSINR treatment is to be pursued until the obtaining either of a serum creatinine less than 130 mmol/L or of a drop of at least 30 % in the serum creatinine with respect to the value measured at the time of diagnosis of hepatorenal syndrome. The standard average duration of treatment is 10 days. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Infrequently, acrocyanosis, diarrhea, abdominal cramps, headache.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

## Glypressin inj 0.1mg/mL, 8.5mL

| TAH Drug Code      | [IGLYP8](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IGLYP8)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Bleeding oesophageal varices, and hepatorenal syndrome (HRS) Type 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | [Bleeding oesophageal varices] Initial: 2 ampoules IV Q4H, maintained until bleeding has been controlled but up to a maximum of 48 hours. Body weight <50kg : 1 ampoule IV Q4H; maintenance dosage (if necessary), 1 ampoule IV Q4H for a maximum of 3 days. Duration of treatment must not exceed 5 days. [Type 1 hepatorenal syndrome] 3-4 ampoules IV Q24H, divided as 3 or 4 administrations. In the absence of any reduction of the serum creatinine after 3 days of treatment, cessation of treatment is advised. In the other cases, treatment is to be pursued until the obtaining either of a serum creatinine < 130 Î¼mol/litre or of a drop of at least 30 % in the serum creatinine with respect to the value measured at the time of diagnosis of hepatorenal syndrome. The standard average duration of treatment is 10 days. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Pregnancy. Hypersensitivity to terlipressin or to any of the excipients. In patients with septic shock with a low cardiac output terlipressin should not be used. Contraindicated in patients with current or recent (within the last 3 months) ischaemic cardiovascular disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | (1-10%) Paleness, hypertension, abdominal pain, nausea, and diarrhea. Hyponatremia, ischemia, bradycardia, respiratory failure, and Torsade de pointes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

